In gastric cancer patients, VEGF-A and VEGF-C are associated with large tumor size, higher peritumoral lymphatic vessel density, microvessel density, lymphatic vessel invasion, lymph node metastasis, and worse prognosis [51]. This evidence concerns the gene VEGFC and gastric cancer.